SUA levels | Cases/n (%) | Model 1 | Model 2 | ||||
---|---|---|---|---|---|---|---|
OR | 95% CI | P | OR | 95% CI | P | ||
Total (n = 7569) | |||||||
Q1 | 176/1523 (11.6) | 1 | Â | Â | 1 | Â | Â |
Q2 | 338/1536 (22.0) | 2.41 | 1.97–2.95 | < 0.001 | 1.78 | 1.41–2.23 | < 0.001 |
Q3 | 473/1521 (31.1) | 4.39 | 3.61–5.34 | < 0.001 | 2.85 | 2.27–3.58 | < 0.001 |
Q4 | 540/1481 (36.5) | 6.31 | 5.16–7.72 | < 0.001 | 3.19 | 2.52–4.04 | < 0.001 |
Q5 | 702/15,084 (6.6) | 10.92 | 8.88–13.44 | < 0.001 | 4.34 | 3.39–5.54 | < 0.001 |
Men (n = 3126) | |||||||
Q1 | 98/603 (16.3) | 1 | Â | Â | 1 | Â | Â |
Q2 | 147/646 (22.8) | 1.48 | 1.11–1.97 | 0.008 | 1.20 | 1.01–1.84 | 0.281 |
Q3 | 197/617 (31.9) | 2.38 | 1.80–3.14 | < 0.001 | 1.57 | 1.14–2.17 | 0.006 |
Q4 | 221/629 (35.1) | 2.93 | 2.22–3.86 | < 0.001 | 1.94 | 1.41–2.67 | < 0.001 |
Q5 | 304/631 (48.2) | 5.26 | 4.01–6.90 | < 0.001 | 2.74 | 2.00–3.76 | < 0.001 |
Women (n = 4443) | |||||||
Q1 | 82/873 (9.4) | 1 | Â | Â | 1 | Â | Â |
Q2 | 152/881 (17.3) | 2.04 | 1.53–2.71 | < 0.001 | 1.70 | 1.24–2.34 | 0.001 |
Q3 | 226/910 (24.8) | 3.27 | 2.48–4.29 | < 0.001 | 2.27 | 1.67–3.08 | < 0.001 |
Q4 | 355/878 (40.4) | 6.83 | 5.23–8.91 | < 0.001 | 4.07 | 3.02–5.48 | < 0.001 |
Q5 | 447/901 (49.6) | 10.19 | 7.80–13.31 | < 0.001 | 4.60 | 3.39–6.24 | < 0.001 |